KEDPLASMA USA, established in 2004, specializes in the collection and procurement of high-quality plasma that is processed into plasma-based therapies. With over 500 employees, KEDPLASMA USA operates 12 plasma centers in the United States. We are located in Alabama, California, Florida, Mississippi, New York, North Carolina, South Carolina, Tennessee, and Virginia.
KEDPLASMA is a subsidiary of Kedrion Biopharma, an international company that produces and distributes plasma-derived medicinal products for use in treating severe diseases, disorders and conditions such as hemophilia and immune system deficiencies.
